Tag: Science

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Lucas Siow of ProteinQure on how they’re combining quantum computing, reinforcement learning, and molecular simulations to design protein-based therapeutics.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with John Cassidy, CEO of Cambridge Cancer Genomics. CCG is using liquid biopsy, genomics, and artificial intelligence to predict cancer disease progression and improve its treatment.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Kristen Fortney, founder and CEO of BioAge Labs. Kristen leads one of just a few companies focused explicitly on aging itself, rather than just the diseases for which aging puts people at greater risk.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Sam Cooper, cofounder and CEO of Phenomic AI. Sam and his team use machine learning for automated image analysis to study cell biology and screen drugs. But that’s just the beginning.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Shai Shen-Orr, chief scientist of CytoReason, about systems immunology, its potential in medicine, and how CytoReason applies artificial intelligence to make sense of the growing body of immune-related data.

For this episode of the Artificial Intelligence in Drug Discovery podcast, I spoke with Leila Pirhaji of ReviveMed about metabolomics for diagnosis and treatment, and how ReviveMed is using AI to realize its potential.